AAAAAA

   
Results: 1-7 |
Results: 7
[Br-76]bromodeoxyuridine PET in tumor-bearing animals
Authors: Gardelle, O Roelcke, U Vontobel, P Crompton, NEA Guenther, I Blauenstein, P Schubiger, AP Blattmann, H Ryser, JE Leenders, KL Kaser-Hotz, B
Citation: O. Gardelle et al., [Br-76]bromodeoxyuridine PET in tumor-bearing animals, NUCL MED BI, 28(1), 2001, pp. 51-57
In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors
Authors: Garcia-Garayoa, E Allemann-Tannahill, L Blauenstein, P Willmann, M Carrel-Remy, N Tourwe, D Iterbeke, K Conrath, P Schubiger, PA
Citation: E. Garcia-garayoa et al., In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors, NUCL MED BI, 28(1), 2001, pp. 75-84
Synthesis, radiolabelling and biological characterization of (D)-7-iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione, a glycine-binding site antagonist of NMDA receptors
Authors: Ametamey, SM Kokic, M Carrey-Remy, N Blauenstein, P Willmann, M Bischoff, S Schmutz, M Schubiger, PA Auberson, YP
Citation: Sm. Ametamey et al., Synthesis, radiolabelling and biological characterization of (D)-7-iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione, a glycine-binding site antagonist of NMDA receptors, BIOORG MED, 10(1), 2000, pp. 75-78
Radiopharmaceuticals for targeted tumor diagnosis and therapy
Authors: Waibel, R Novak-Hofer, I Schibli, R Blauenstein, P Garcia-Garayoa, E Schwarzbach, R Zimmermann, K Pellikka, R Gasser, O Blanc, A Bruhlmeier, M Schubiger, PA
Citation: R. Waibel et al., Radiopharmaceuticals for targeted tumor diagnosis and therapy, CHIMIA, 54(11), 2000, pp. 683-688
Catabolism of neurotensins - Implications for the design of radiolabeling strategies of peptides
Authors: Schubiger, PA Allemann-Tannahill, L Egli, A Schibli, R Alberto, R Carrel-Remy, N Willmann, M Blauenstein, P Tourwe, D
Citation: Pa. Schubiger et al., Catabolism of neurotensins - Implications for the design of radiolabeling strategies of peptides, Q J NUCL M, 43(2), 1999, pp. 155-158
[Br-76]Bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography, in vitro and in vivo studies in mice
Authors: Ryser, JE Blauenstein, P Remy, N Weinreich, R Hasler, PH Novak-Hofer, I Schubiger, PA
Citation: Je. Ryser et al., [Br-76]Bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography, in vitro and in vivo studies in mice, NUCL MED BI, 26(6), 1999, pp. 673-679
Non-invasive assessment of tumour cell proliferation with positron emission tomography and [Br-76]bromodeoxyuridine
Authors: Boni, R Blauenstein, P Dummer, R von Schulthess, GK Schubiger, PA Steinert, HC
Citation: R. Boni et al., Non-invasive assessment of tumour cell proliferation with positron emission tomography and [Br-76]bromodeoxyuridine, MELANOMA RE, 9(6), 1999, pp. 569-573
Risultati: 1-7 |